Genyan Qin

Genyan Qin

Auto-generated profile, based on publicly available information

Genyan Qin

Changde First Hospital of Traditional Chinese Medicine,Department of Ophthalmology,Hunan,China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2019 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
GQGenyan Qin
Genyan Qin
YZYasha Zhou
Yasha Zhou
JPJun Peng
Jun Peng
YZYouwei Zhang
Youwei Zhang
XPXiaofang Peng
Xiaofang Peng
YYYi Jing Yang
Yi Jing Yang
The purpose of this study was to investigate the effects of Buddleja officinalis Maxim eye drops on morphology and apoptosis in lacrimal glands of the experimental dry eye rabbit model. A total of thirty-six male rabbits were divided into six study groups, consisting of the control group and the dry eye rabbit model group (without any treatment), the dry eye rabbit model group treated with testosterone, and the dry eye rabbit model group treated with different concentrations of Buddleja officinalis Maxim eye drops (1.0 mg/ml, 1.5 mg/ml and 3.0 mg/ml). The lacrimal glands were evaluated by hematoxylin-eosin staining and immunohistochemistry. Buddleja officinalis Maxim eye drops can improve the morphological structure of the lacrimal gland in the dry eye model of castrated rabbits. The average optical density values of PI3K, Akt, and caspase-9 protein in the lacrimal gland tissue of the 3 mg/ml Buddleja officinalis Maxim eye drops group were significantly different from those in the model group (P<0.01) and similar to the testosterone control group and the control group (P>0.05). Buddleja officinalis Maxim eye drops can improve the morphological structure of the lacrimal gland in the dry eye model of castrated rabbits.

6 August 2025
Verified
Conference Paper
Closed access
GQGenyan Qin
Genyan Qin
NXNing Xu
Ning Xu
JXJian Xu
Jian Xu
Diabetic Retinopathy (DR) remains a leading cause of blindness globally, driving rapid development of automated diagnostic systems leveraging deep learning. Recent research demonstrates that multimodal deep learning models that integrate retinal images, electronic health records (EHR), and clinical text data can surpass single-modality approaches in DR screening accuracy. In this survey, we systematically review advances from the last three years, highlighting key models, methodologies, as well as datasets and evaluation metrics. We find multimodal approaches consistently outperform single modality models, and often by a clear margin, and identify data scarcity, domain adaptation, and interpretability as the three main hurdles ahead.

1 January 2026 in Journal of Ophthalmology
Verified
Journal Article
Open access
GQGenyan Qin
Genyan Qin
QPQinghua Peng
Qinghua Peng
YZYasha Zhou
Yasha Zhou
JPJun Peng
Jun Peng
QLQing Liu
Qing Liu
JXJian Xu
Jian Xu
Diabetic retinopathy (DR) remains a leading cause of blindness globally, driving the rapid development of automated diagnostic systems leveraging deep learning. Recent research demonstrates that multimodal deep learning models that integrate retinal images, electronic health records (EHR), and clinical text data can surpass single‐modality approaches in DR screening accuracy. In this survey, we systematically review advances from the last 3 years, highlighting key models and methodologies, as well as datasets and evaluation metrics. We find multimodal approaches consistently outperform single‐modality models, and often by a clear margin, and identify data scarcity, domain adaptation, and interpretability as the three main hurdles ahead.

18 February 2018 in International Journal of Ophthalmology
Verified
Journal Article
Open access
YZYa-Sha Zhou
Ya-Sha Zhou
JXJian Xu
Jian Xu
JPJun Peng
Jun Peng
YLYue Liu
Yue Liu
GQGen-Yan Qin
Gen-Yan Qin
HTHanyu Tan
Hanyu Tan
The study investigated the effects of Qingguang'an II (a Chinese medicinal preparation) on expressions of OX42 protein and interleukin-1 beta (IL-1 beta) mRNA of retinal microglia cells of rats with chronic high intraocular pressure (IOP). SD rats were randomly divided into 6 groups, that were: A: blank group; B: model group; C: Qingguang'an II low dose group; D: Qingguang'an II medium dose group; E: Qingguang'an II high dose group; F: Yimaikang disket (a Chinese medicinal preparation) group. Experimental rats in B, C, D, E, F groups were established the model of chronic high IOP by cauterizing of superficial scleral vein. Tissues of eyes were obtained after intragastric administration for 2 and 4wk. At the time-point of 2wk, OX42 protein and IL-1 beta mRNA in group B were statistically expressed in higher level comparing with other groups (P<0.05). Moreover, at the time-point of 4wk, OX42 protein and IL-1 beta mRNA in groups C, D and E were statistically expressed in lower level comparing with group F (P<0.05). Besides, OX42 protein and IL-1 beta mRNA in groups C and D were statistically expressed in higher level comparing with group E (P0.05). The study indicated that, in the protection of optic nerve of rats with chronic high IOP, the high dose of Qingguang'an II at the time-point of 4wk was the better choice.